Liposome targeting to tumors using vitamin and growth factor receptors

Vitamins and Hormones

Volumn 60, Issue , 2000, Pages 285-332

  Drummond, Daryl C ^a   Hong, Keelung ^a   Park, John W ^b   Benz, Christopher C ^b   Kirpgtin, Dmitri B ^a,b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARRIER PROTEIN; CELL SURFACE RECEPTOR; FOLATE BINDING PROTEIN; FOLATE-BINDING PROTEIN; FOLIC ACID; GROWTH FACTOR RECEPTOR; LIGAND; LIPOSOME; VITAMIN;

CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; HUMAN; IN VITRO STUDY; METABOLISM; METHODOLOGY; NEOPLASM; REVIEW;

ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; DRUG DELIVERY SYSTEMS; FOLIC ACID; HUMANS; LIGANDS; LIPOSOMES; MICROSCOPY, CONFOCAL; NEOPLASMS; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; VITAMINS;

EID: 0033641787     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0083-6729(00)60022-5     Document Type: Review

References (196)

1. T.M. Allen A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles Biochim. Biophys. Acta 640 1981 385 397
2. T.M. Allen Liposomal drug formulations: Rationale for development and what we can expect in the future Drugs 56 1998 747 756
3. T.M. Allen D. Papahadjopoulos Sterically stabilized (“stealth”) liposomes: pharmacokinetic and therapeutic advantages G. Gregoriadis Liposome Technology: Interactions of Liposomes with the Biological Milieu Vol. III 1993 CRC Press Boca Raton, FL 59 72
4. T.M. Allen C. Hansen F. Martin C. Redemann A. Yau-Young Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1066 1991 29 36
5. ®) liposomes J. Liposome Res. 4 1994 125
6. T.M. Allen C.B. Hansen D.E. Lopes de Menezes Pharmacokinetics of long-circulating liposomes Adv. Drug Del. Rev. 16 1995 267 284
7. T.M. Allen E. Brandeis C.B. Hansen G.Y. Kao S. Zalipsky A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells Biochim. Biophys. Acts 1237 1995 99 108
8. T.M. Allen C.B. Hansen G.Y. Kao J. Ma J.M.J. Marjan Antibody-targeted liposomes: Prospects and problems Adv. Drug Del. Rev. 24 1997 243
9. T.M. Allen C.B. Hansen D.D. Stuart Targeted sterically stabilized liposomal drug delivery D.D. Lasic D. Papahadjopoulos Medical Applications of Liposomes 1998 Elsevier New York 545 565
10. A.C. Antony The biological chemistry of folate receptors Blood 7 1992 2807 2820
11. A.C. Antony M.A. Kane R.M. Portillo P.C. Elwood J.F. Kolhouse Studies of the role of a particular folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells J. Biol. Chem. 260 1985 14911 14917
12. D. Aragnol L.D. Leserman Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo Proc. Natl. Acad. Sci. USA 83 1986 2699 2703
13. M.B. Bally H. Lim P.R. Cullis L.D. Mayer Controlling the drug delivery attributes of lipid-based drug formulations J. Liposome Res. 8 1998 299 335
14. A.D. Bangham Physical structure and behavior of lipids and lipid enzymes Adv. Lipid Res. 1 1963 65 104
15. A.D. Bangham M.M. Standish J.C. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
16. J. Baselga D. Tripathy J. Mendelsohn S. Baughman C.C. Benz Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer Semin. Oncol. 26 1999 78 83
17. B. Becerril M.A. Poul J.D. Marks Toward selection of internalizing antibodies fron phage display libraries Biochem. Biophys. Res. Commun. 255 1999 386 393
18. J.G. Beitz P. Davol J.W. Clark J. Kato M. Medina Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo Cancer Res. 52 1992 227 230
19. A. Berchuck A. Kamel R. Whitaker B. Kerns G. Olt Overexpression of HER-2/neu is associtated with poor survival in advanced epithelial ovarian cancer Cancer Res. 50 1990 4087 4091
20. A.L. Boerger S. Snitkovsky J.A. Young Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types Proc. Natl. Acad. Sci. USA 96 1999 9867 9872
21. Å. Borg A.K. Tandon H. Sigurdsson G.M. Clark M. Fernö HER-2/ neu amplification predicts poor survival in node-positive breast cancer Cancer Res. 50 1990 4332 4337
22. J.Y. Chang W. Xia R. Shao F. Sorgi G.N. Hortobagyi The tumor suppression activity of ElA in HER-2/neu-overexpressing breast cancer Oncogene 14 1997 561 568
23. S.A. Chrysogelos R.B. Dickson EGF receptor expression, regulation, and function in breast cancer Breast Cancer Res. Treatment 29 1994 29 40
24. G. Citro D. Perrotti C. Cucco I. D'Agnano A. Sacchi Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides Proc. Natl. Acad. Sci. USA 89 1992 7031 7035
25. G. Citro C. Szczylik P. Ginobbi G. Zupi B. Calabretta Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells Br. J. Cancer 69 1994 463 467
26. P.R. Cullis M.J. Hope M.B. Bally T.D. Madden L.D. Mayer D.B. Fenske Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into lagre unilamellar vesicles Biochim. Biophys. Acta 1331 1997 187 211
27. J. Damen J. Regts G. Scherphof Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins: Dependence on cholesterol content and phospholipid composition Biochim. Biophys. Acta 665 1981 538 545
28. M.C. De Lima S. Simoes P. Pires R. Gaspar V. Slepushkin N. Düzgünes Gene delivery mediated by cationic liposomes: From biophysical aspects to enhancement of transfection Mol. Membr Biol. 16 1999 103 109
29. C. De Vries J.A. Escobedo H. Ueno K. Houck N. Ferrara L.T. Williams The fins-like tyrosine kinase, a receptor for vascular endothelial growth factor Science 255 1992 989 991
30. W.F. De Weerd L.M. Leeb-Lundberg Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells J. Biol. Chem. 272 1997 17858 17866
31. R.J. Debs T.D. Heath D. Papahadjopoulos Targeting of anti-Thy 1.1 monoclonal antibody conjugated liposomes in Thy 1.1 mice after intravenous administration Biochim. Biophys. Acta 901 1987 183 190
32. J.T.P. Derksen H.W.M. Morselt G.L. Scherphof Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages Biochim. Biophys. Acta 971 1988 127 136
33. D.C. Drummond D.L. Daleke Synthesis and characterization of N-acylated, pH-sensitive ‘caged’ aminophospholipids Chem. Phys. Lipids 75 1995 27 41
34. D.C. Drummond D.L. Daleke Development of pH-sensitive liposomes composed of a novel “caged” dioleoylphosphatidylethanolamine Biophys. J. 72 1997 A13
35. D.C. Drummond O.M. Meyer K. Hong D. Kirpotin D. Papahadjopoulos Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors Pharmacol. Rev. 51 1999 691 743
36. A.D. Ellington J.W. Szostak In vitro selection of RNA molecules that bind specific ligands Nature 346 1990 818 822
37. J. Fan K.S. Vitols F.M. Huennekens Biotin derivatives of methotrexate and folate J. Biol. Chem. 266 1991 14862 14865
38. Z. Fan J. Mendelsohn Therapeutic application of anti-growth factor receptor antibodies Curr. Opinion Oncol. 10 1998 67 73
39. S.B. Fox K. Smith J. Hollyer M. Greenall D. Hastrich A.L. Harris The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients Breast Cancer Res. Treat. 29 1994 41 49
40. A.R. French G.P. Sudlow H.S. Wiley D.A. Lauffenburger Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions J. Biol. Chem. 269 1994 15749 15755
41. K. Fujimori D.G. Covell J.E. Fletcher J.N. Weinstein A modeling analysis of monoclonal antibody percolation through tumors: A binding site barrier J. Nucl. Med. 31 1990 1191 1198
42. A. Gabizon Clinical trials of liposomes as carriers of chemotherapeutic agents: synopsis and perspective D.D. Lasic D. Papahadjopoulos Medical Applications of Liposomes 1998 Elsevier New York 625 634
43. A. Gabizon Y. Barenholz Liposomal anthracyclines: From basics to clinical approval of PEGylated liposomal doxorubicin A.S. Janoff Liposomes: Rational Design 1999 Marcel Dekker New York 343 362
44. A. Gabizon D. Papahadjopoulos Liposome formulations with prolonged circulation time in blood and enhanced uptake in tumors Proc. Natl. Acad. Sci. USA 85 1988 6949 6953
45. A. Gabizon D. Goren A.T. Horowitz D. Tzemach A. Lossos T. Siegal Long-circulating liposomes for drug delivery in cancer therapy: A review of biodistribution studies in tumor-bearing animals Adv. Drug Delivery. Rev. 24 1997 337 344
46. A. Gabizon A.T. Horowitz D. Goren D. Tzemach F. Mandelbaum-Shavit Targeting folate receptor with folate linked to extremeties of poly(ethlene glycol)grafted liposomes: in vitro studies Bioconjugate Chem. 10 1999 289 298
47. P. Garin-Chesa I. Campbell P.E. Saigo J.L. Lewis Jr. L.J. Old W.J. Rettig Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein Am. J. Pathol. 14 1993 557 567
48. K.A. Gelmon A. Tolcher A.R. Diab M.B. Bally L. Embree Phase I study of liposomal vincristine J. Clin. Oncol. 17 1999 697 705
49. P. Ginobbi T.A. Geiser G. Citro Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells Anticancer Res. 17 1997 29 36
50. R.I. Goldberg R.M. Smith L. Jarett Insulin and alpha 2-macroglobulinmethylamine undergo endocytosis by different mechanisms in rat adipocytes. I. Comparison of cell surface events J. Cell. Physiol. 133 1987 203 212
51. C.K. Goldman B.E. Rogers J.T. Douglas B.A. Sosnowski W. Ying Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor Cancer Res. 57 1997 1447 1451
52. D. Goren A.T. Horowitz S. Zalipsky M.C. Woodle Y. Yarden A. Gabizon Targeting of stealth liposomes to erbB-2 (Her/2) receptor: In vitro and in vivo studies Br. J. Cancer 74 1996 1749 1756
53. S. Gottschalk R.J. Cristiano L.C. Smith S.L. Woo Folate receptor mediated DNA delivery into tumor cells: Potosomal disruption results in enhanced gene expression Gene Ther. 1 1994 185 191
54. M.L. Grossbard A.S. Freedman J. Ritz F. Coral V.S. Goldmacher Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: A phase I trial of daily bolus infusion Blood 79 1992 576 585
55. M.L. Grossbard J.M. Lambert V.S. Goldmacher N.L. Spector J. Kinsella Anti-B4-blocked ricin: A phase I trial of 7-day continuous infusion in patients with B-cell neoplasms J. Clin. Oncol. 11 1993 726 737
56. D.L. Gu A.M. Gonzalez M.A. Printz J. Doukas W. Ying Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: Evidence for reduced toxicity and enhanced antitumor activity in mice Cancer Res. 59 1999 2608 2614
57. G. Haran R. Cohen L.K. Bar Y. Barenholz Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphiphathic weak bases Biochim. Biophys. Acta 1151 1993 201 215
58. T.O. Harasym P. Tardi S.A. Longman S.M. Ansell M.B. Bally Poly(ethylene glycol)-modified phospholipids prevent aggregation during covalent conjugation of proteins to liposomes Bioconjugate Chem. 6 1995 187 194
59. J.A. Harding C.M. Engbers M.S. Newman N.I. Goldstein S. Zalipsky Immunogenicity and pharmacokinetic attributes of poly(ethyleneglycol)-grafted immunoliposomes Biochim. Biophys. Acta 1327 1997 181 192
60. G.B. Henderson Folate-binding proteins Ann. Rev. Nutr. 10 1990 319 335
61. S.K. Hobbs W.L. Monsky F. Yuan W.G. Roberts L. Griffith V.P. Torchilin R.K. Jain Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment Proc. Natl Acad. Sci. USA 95 1998 4607 4612
62. S.R. Holladay Z.-F. Yang M.D. Kennedy C.P. Leamon R.J. Lee M. Jayamani T. Mason P.S. Low Riboflavin-mediated delivery of a macromolecule into cultured human cells Biochim. Biophys. Acta 1426 1999 195 204
63. J. Holm S.I. Hansen M. Hoier-Madsen L. Bostad High-affinity folate binding in human choroid plexus: Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding protein Biochem. J. 280 1991 267 271
64. J. Holm S.I. Hansen M. Hoier-Madsen L. Bostad A high-affinity folate binding protein in proximal tubule cells of human kidney Kidney Int. 41 1992 50 55
65. J. Holm S.I. Hansen K. Sondergaard M. Hoier-Madsen The high-affinity folate binding protein in normal and malignant mammary gland tissue Adv. Exp. Med. Biol. 338 1993 757 760
66. G.N. Hortobagyi M.C. Hung G. Lopez-Berestein A Phase I multicenter study of ElA gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer Hum. Gene Ther. 9 1998 1775 1798
67. A. Huang S.J. Kennel L. Huang Interactions of immunoliposomes with target cells J. Biol. Chem. 258 1983 14034 14040
68. M.C. Hung Y.K. Lau Basic science of HER-2/neu: a review Semin. Oncol. 26 1999 51 59
69. M.C. Hung J.Y.J. Chang X.M. Xing Preclinical and clinical study of HER2/neu-targeting cancer gene therapy Adv. Drug Deliv. Rev. 30 1998 219 227
70. E. Hurwitz I. Stancovski M. Sela Y. Yarden Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake Proc. Natl. Acad. Sci. USA 92 1995 3353 3357
71. K.J. Huang Liposome pharmacokinetics M.J. Ostro Liposomes: From Biophysics to therapeutics 1987 Marcel Dekker New York 109 156
72. N.E. Hynes D.F. Stern The biology of erbB-2/neu/HER-2 and its role in cancer Biochim. Biophys. Acta 1198 1994 165 184
73. ® liposomes (DXR-SL) Proc. Int. Symp. Control. Rel. Bioact. Mater. 26 1999 785 786
74. Y. Ishii Y. Aramaki T. Hara S. Tsuchiya T. Fuwa Preparation of EGF-labeled liposomes and their uptake by hepatocytes Biochem. Biophys. Res. Commun. 160 1989 732 736
75. H. Jinno M. Ueda S. Ozawa K. Kikuchi T. Ikeda Epidermal growth factor receptor-dependent cytotoxic effect by an EGF-ribonuclease conjugate on human cancer cell lines—A trial for less immunogenic chimeric toxin Cancer Chemother. Pharmacol. 38 1996 303 308
76. M. Juweid R. Neumann C. Paik M.J. Perez-Bacete J. Sato W. van Osdol J.N. Weinstein Micropharmacology of monoclonal antibodies in solid tumors: Direct experimental evidence for a binding site barrier Cancer Res. 52 1992 5144 5153
77. B.A. Kamen M.-T. Wang A.J. Streckfuss X. Peryea R.G.W Anderson Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles J. Biol. Chem. 263 1988 13602 13609
78. M.A. Kane P.C. Elwood R.M. Portillo A.C. Antony J.F. Kolhouse The interrelationship of the soluble and membrane-associated folate-binding proteins in human KB cells J. Biol. Chem. 261 1986 15625 15631
79. M.A. Kane S. Waxman Biology of disease: Role of folate binding proteins in folate metabolism Lab. Invest. 60 1989 737 746
80. G.Y. Kao L.-J. Chang T.M. Allen Use of targeted cationic liposomes in enhanced DNA delivery to cancer cells Cancer Gene Ther. 3 1996 250 256
81. A. Kikuchi S. Sugaya H. Ueda K. Tanaka Y. Aramaki Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes Biochem. Biophys. Res. Commun. 227 1996 666 671
82. D. Kirpotin J.W. Park K. Hong S. Zalipsky W-L. Li Sterically stabilized anti-HER2 immunoliposomes: Design and targeting to human breast cancer cells in vitro Biochemistry 36 1997 66 75
83. D.B. Kirpotin J.W. Park K. Hong Y. Shao R. Shalaby Targeting of liposomes to solid tumors: The case of sterically stabilized anti-HER2 immunoliposomes J Liposome Res. 7 1997 391 417
84. D.B. Kirpotin J.W. Park K. Hong Y. Shao G. Colbern Targeting of sterically stabilized liposomes to cancers overexpressing HER2/neu proto-oncogene D.D. Lasic D. Papahadjopoulos Medical Applications of Liposomes 1998 Elsevier New York 325 345
85. D.B. Kirpotin K. Hong J.W. Park R. Shalaby U.B. Nielsen W. Zheng Y. Shao J.D. Marks C.C. Benz D. Papahadjopoulos Anti-HER2 immunoliposomes produced by spontaneous incorporation of an amphipathic poly(ethylene glycol)-antibody conjugate into the liposome membrane Proc. 91st Ann. Meet Am. Assoc Cancer Res. 2000 (submitted)
86. D.B. Kirpotin K. Hong J.W. Park Y. Shao M.R. Shalaby G.C. Colbern C.C. Benz D. Papahadjopoulos Localization of anti-HER2 immunoliposomes in HER2- overexpressing breast cancer xenografts: Intracellular delivery via immuno-targeting Nature Biotechnol. 2000 (submitted)
87. A.L. Klibanov K. Maruyama V.P. Torchilin L. Huang Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1990 235 237
88. T. Knepper M. Przybylski M. Ahlers H. Ringsdorf Methotrexate- and folate-lipid conjugates of defined chemical structures as antifolate analogs and transport probes Chemistry and Biology of Pteridines 1989 1990 W de Gruyter Berlin 1280 1283
89. M. Koppan A. Nagy A.V. Schally A. Plonowski G. Halmos J.M. Arencibia K. Groot Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice The Prostate 38 1999 151 158
90. V.T. Kung C.T. Redemann Synthesis of carboxyacyl derivatives of phosphatidylethanolamine and use as an efficient method for conjugation of protein to liposomes Biochim. Biophys. Acta 862 1986 435 439
91. D. Lasic Liposomes: From Physics to Applications 1993 Elsevier Amsterdam
92. D.D. Lasic D. Papahadjopoulos Medical Applications of Liposomes 1998 Elsevier Amsterdam
93. C.P. Leamon P.S. Low Delivery of macromolecules into living cells: A method that exlpoits folate receptor endocytosis Proc. Natl. Acad. Sci. USA 88 1991 5572 5576
94. C.P. Leamon P.S. Low Cytotoxicity of momordin-folate conjugates in cultured human cells J. Biol. Chem. 267 1992 24966 24971
95. C.P. Leamon I. Pastan P.S. Low Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells: Contribution of translocation domain J. Biol. Chem. 268 1993 24854 24874
96. R.J. Lee L. Huang Folate-targeted, anionic liposome-entrapped polylysinecondensed DNA for tumor cell-specific gene transfer J. Biol. Chem. 271 1996 8481 8487
97. R.J. Lee P.S. Low Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis J. Biol. Chem. 269 1994 3198 3204
98. R.J. Lee P.S. Low Folate-mediated tumor cell targeting of liposomeentrapped doxorubicin in vitro Biochim. Biophys. Acta 1233 1995 134 144
99. R.J. Lee S. Wang P.S. Low Measurement of endosome pH following folate receptor-mediated endocytosis Biochim. Biophys. Acta 1312 1996 237 242
100. R.J. Lee S. Wang M.J. Turk P.S. Low The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery Biosci. Rep. 18 1998 69 78
101. HER2 monoclonal antibodies Cancer Immunol. Immunother 37 1993 255 263
102. Q. Liu P.M. Kane P.R. Newman M. Forgac Site-directed mutagenesis of the yeast V-ATPase β subunit (Vma2p) J. Biol. Chem. 271 1996 2018 2022
103. D.E. Lopes de Menezes L.M. Pilarski T.M. Allen In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma Cancer Res. 58 1998 3320 3330
104. P.S. Low M.A. Horn P.F. Heinstein Composition and method for tumor imaging 1997 U.S. Patent US 5,688,488
105. P.S. Low M.A. Horn P.F. Heinstein Method for enhancing transmembrane transport of exogenous molecules 1997 U.S. Patent US 5,635,382
106. J.Y. Lu D.A. Lowe M.D. Kennedy P.S. Low Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug J. Drug Target 7 1999 43 53
107. P. Machy J. Barbet L.D. Leserman Differential endocytosis of T and B lymphocyte surface molecules evaluated with antibody-bearing fluorscent liposomes containing methotrexate Immunology 79 1982 4148 4152
108. P.E. Mansson P. Adams M. Kan W.L. McKeehan Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors Cancer Res. 49 1989 2485 2494
109. J.D. Marks H.R. Hoogenboom A.D. Griffiths G. Winter Molecular evolution of proteins on filamentous phage: Mimicking the strategy of the immune system J. Biol. Chem. 267 1992 16007 16010
110. F.J. Martin Clinical pharmacology and antitumor efficacy of DOXIL (pegylated liposomal doxorubicin) D.D. Lasic D. Papahadjopoulos Medical Applications of Liposomes 1998 Elsevier New York 635 688p
111. F.J. Martin D. Papahadjopoulos Irreversible coupling of immunoglobulin fragments to preformed vesicles: An improved method for liposome targeting J. Biol. Chem. 257 1982 286 288
112. F.J. Martin W.L. Hubbell D. Papahadjopoulos Immunospecific targeting of liposomes to cells: A novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds Biochemistry 20 1981 4229 4238
113. C.J. Mathias S. Wang R.J. Lee D.J. Waters P.S. Low M.A. Green Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of Gallium-67-deferoxamine-folate J. Nucl. Med. 37 1996 1003 1008
114. C.J. Mathias S. Wang D.J. Waters J.J. Turek P.S. Low M.A. Green Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical J. Nucl. Med. 39 1998 1579 1585
115. 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts Nucl. Med. Biol. 26 1999 23 25
116. L.D. Mayer M.B. Bally M.J. Hope P.R. Cullis Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential Biochim. Biophys. Acta 816 1985 294 302
117. E. Mayhew Y.M. Rustum F. Szoka D. Papahadjopoulos Role of cholesterol in enhancing the antitumor activity of cystosine arabinoside entrapped in liposomes Cancer Treatment Rep. 63 1979 1923 1928
118. S. Mayor K.G. Rothberg F.R. Maxfield Sequesteration of GPI-anchored proteins in caveolae triggered by cross-linking Science 264 1994 1948 1951
119. 12 Bioconjugate Chem. 10 1999 1131 1136
120. O. Meyer D. Kirpotin K. Hong B. Sternberg J.W. Park Cationic liposomes coated with polyethylene glycol as carriers of oligonucleotides J. Biol. Chem. 273 1998 15621 15627
121. C. Mineo R.G. Anderson A vacuolar-type proton ATPase mediates acidification of plasmalemmal vesicles during potocytosis Exp. Cell Res. 224 1996 237 242
122. A. Mori A.L. Klibanov V.P. Torchilin L. Huang Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo FEBS Lett. 284 1991 263 266
123. F.M. Muggia J.D. Hainsworth S. Jeffers P. Miller S. Groshen Phase II study of liposomal doxorubicin in refactory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation J. Clin. Oncol. 15 1997 987 993
124. M. Muller M. Dietel A. Turzynski K. Wiechen Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells Int. J. Cancer 77 1998 567 571
125. P.S. Multani M.L. Grossbard Monoclonal antibody-based therapies for hematological malignancies J. Clin. Oncol. 16 1998 3691 3710
126. J.W. Nichols D.W. Deamer Catecholamine uptake and concentration by liposomes maintaining pH gradients Biochim. Biophys. Acta 455 1976 269 271
127. G.A. Niehaus T.P. Singleton D. Dykoski D.T. Kiang Stability of HER2/neu expression over time and at multiple metastatic sites J. Natl. Cancer Inst. 85 1993 1230 1235
128. U.B. Nielsen M.A. Poul E.M. Pickering D. Kirpotin R. Shalaby K. Hong J.W. Park D. Papahadjopoulos C.C. Benz J.D. Marks Targeting of breast tumors with scFv antibodies selected for internalization from a phage display li brary Proc.Intern. Conf Mol. Targets Cancer Therapeut. Clin. Cancer Res. 5 1999 (Suppl.). [Abstract 92]
129. D.W. Northfelt B.J. Dezube J.A. Thommes B.J. Miller M.A. Fischl Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial J. Clin. Oncol. 16 1998 2445 2451
130. D. Papahadjopoulos T.M. Allen A. Gabizon E. Mayhew K. Matthay Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. USA 88 1991 11460 11464
131. D. Papahadjopoulos S. Nir S. Oki Permeability properties of phospholipid membranes: effect of cholesterol and temperature Biochim. Biophys. Acta 266 1972 561 583
132. J.W. Park K. Hong P. Carter H. Asgari L.Y. Guo Development of anti-p185HER2 immunoliposomes for cancer therapy Proc. Natl. Acad. Sci. USA 92 1995 1327 1331
133. J.W. Park K. Hong D.B. Kirpotin O. Meyer D. Papahadjopoulos C.C. Benz Anti-HER2 immunoliposomes for targeted therapy of human tumors Cancer Lett. 118 1997 153 160
134. J.W. Park K. Hong D.B. Kirpotin D. Papahadjopoulos C.C. Benz Immunoliposomes for cancer treatment Adv. Pharmacol. 40 1997 399 435
135. J.W. Park K. Hong D.B. Kirpotin O. Meyer D. Papahadjopoulos C.C. Benz Anti-HER2 immunoliposomes for targeted therapy of human tumors Cancer Lett. 118 1997 153 160
136. J. Park K. Hong W. Zheng C. Benz D. Papahadjopoulos Development of liposome- and anti-HER2 immunoliposome-plasmid complexes for efficient and selective gene delivery Proc Am Assoc Cancer Res 38 1997 342a
137. J.W. Park D. Kirpotin K. Hong G. Colbern R. Shalaby Anti-HER2 immunoliposomes for targeted drug delivery Med. Chem. Res. 8 1998 383 391
138. J.W. Park D. Kirpotin K. Hong W. Zheng Y. Shao Sterically stabilized immunoliposomes: Formulations for delivery of drugs and genes to tumor cells in vivo G. Gregoriadis F. McCormack Targeting of Drugs: Strategies for Stealth Therapeutic Systems Vol. 6 1998 Plenum New York 41 47
139. J.W. Park K. Hong D.B. Kirpotin G. Colbern R. Shalaby J. Baselga Y. Shao U. Nielsen J. Marks D. Moore D. Papahadjopoulos C.C. Benz AntiHER2 immunoliposomes: enhanced anticancer efficacy due to targeted delivery Nat. Biotechnol. 2000 (submitted)
140. I.H. Pastan M.C. Willingham Receptor-mediated endocytosis of hormones in cultured cells Ann. Rev. Physiol. 43 1981 239 250
141. T.A. Patrick D.M. Kranz T.A. van Dyke E.J. Roy Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice J. Neuro-Oncol. 32 1997 111 123
142. M.D. Pegram A. Lipton D.F. Hayes B.L. Weber J.M. Baselga Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu overexpressing metastatic breast cancer refractory to chemotherapy treatment J. Clin. Oncol. 16 1998 2659 2671
143. M.F. Press C. Cordon-Cardo D.J. Slamon Expression of the HER-2/ neu proto-oncogene in normal human adult and fetal tissues Oncogene 5 1990 953 962
144. M.F. Press L. Bernstein P.A. Thomas L.F. Meisner J.-Y. Zhou HER2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas J. Clin. Oncol. 15 1997 2894 2904
145. S. Ramakrishnan T.A. Olson V.L. Bautch D. Mohanraj Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/fik-l-positive endothelial cell proliferation in vitro and angiogenesis in vivo Cancer Res. 56 1996 1324 1330
146. M.R. Ranson J. Carmichael K. O'Byrne S. Stewart D. Smith A. Howell Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: Results of a multicenter phase II trial J. Clin. Oncol. 15 1997 3185 3191
147. M. Ratnam H. Marquardt J.L. Duhring J.H. Freisheim Homologous membrane folate binding proteins in human placenta: Cloning and sequence of a cDNA Biochemistry 28 1989 8249 8254
148. J.A. Reddy L.S. Haneline E.F. Srour A.C. Antony D.W. Clapp Expression and functional characterization of the beta-isoform of the β-isoform of the folate receptor on CD34+ cells Blood 93 1999 3940 3948
149. J.A. Reddy P.S. Low Folate-mediated targeting of therapeutic and imaging agents CRC Crit. Rev. Therap. Drug Carrier Syst. 15 1998 587 627
150. S. Rilnboutt G. Jansen G. Posthuma J.B. Hynes J.H. Schornagel G.J. Strous Endocytosis of GPI-linked membrane folate receptor-α J. Cell Biol. 132 1996 35 47
151. M.L. Rodrigues L.G. Presta C.E. Kotts C. Wirth J. Mordenti Development of a humanized disulfide-stabilized anti-p185HER2 Fv-b-lactamase fusion protein for activation of a cephalosporin doxorubiein prodrug Cancer Res. 55 1995 63 70
152. M.B. Rosenberg X.O. Breakfield E. Hawrot Targeting of liposomes to cells bearing nerve growth factor receptors mediated by biotinylated nerve growth factor J. Neurochem. 48 1987 865 875
153. M.G. Rosenblum L.K. Shawyer J.W. Marks J. Brink L. Cheung B. LangtonWebster Recombinant immunotoxins directed against the c-erb-2/ HER2/neu oncogene product: in vitro cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft models Clin. Cancer Res. 5 1999 865 874
154. J.F. Ross P.K. Chaudhuri M. Ratnam Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines Cancer 73 1994 2432 2443
155. K.G. Rothberg Y. Ying J.F. Kolhouse B.A. Kamen R.G. Anderson The glycophospholipid linked folate receptor internalizes folate without entering the clathrin coated endocytic pathway J. Cell Biol. 110 1990 637 649
156. Y. Rui S. Wang P.S. Low D.H. Thompson Diplasmenylcholine-folate liposomes: An efficient vehicle for intracellular drug delivery J. Am. Chem. Soc. 120 1998 11213 11218
157. E.A. Sausville D. Headlee M. Stetler-Stevenson E.S. Jaffe D. Solomon Continuous infusion ofthe anti-CD22 immunotoxin IgG-RFB4-SMPT dgA in patients with B-cell lymphoma: A phase I study Blood 85 1995 3457 3465
158. H.I. Scher A. Sarkis V. Reuter D. Cohen G. Netto Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms Clin. Cancer Res. 1 1995 545 550
159. R. Schier J.D. Marks Efficient in vitro affinity maturation of phage antibodies using BIAcore guided selections Hum. Antibod. Hybridom. 7 1996 97 105
160. R. Schier A. McCall G.P. Adams K.W. Marshall H. Merritt M. Yim R.S. Crawford L.M. Weiner C. Marks J.D. Marks Isolation of picomolar affinity antic-erbB-2 single-chain Fv by molecular evolution of the complementary determining regions in the center of the antibody binding site J. Mol. Biol. 263 1996 551 567
161. S. Shak Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group Semin. Oncol. 26 1999 71 77
162. C.L. Shapiro T. Ervin L. Welles N. Azarnia J. Keating D.F. Hayes Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastic breast cancer J. Clin. Oncol. 17 1999 1435 1441
163. F. Shen J.F. Ross X. Wang M. Ratnam Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity Biochemistry 33 1994 1209 1215
164. M. Shibuya S. Yamaguchi A. Yamane T. Ikeda A. Tojo Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fins family Oncogene 5 1990 519 524
165. G.P. Sivam P.J. Martin R.A. Reisfeld B.M. Mueller Therapeutic efficacy of a doxorubicin immunoconjugate in a preclinical model of spontaneous metastatic human melanoma Cancer Res. 55 1995 2352 2356
166. D.J. Slamon G.M. Clark S.G. Wong W.J. Levin A. Ullrich W.L. McGuire Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/ neu oncogene Science 235 1987 177 182
167. D.J. Slamon W. Godophin L.A. Jones J.A. Holt S.G. Wong Studies of the HER-2/ neu proto-oncogene in human breast and ovarian cancer Science 244 1989 707 712
168. E.J. Smart D.C. Foster Y.S. Ying B.A. Kamen R.G.W. Anderson Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae J. Cell Biol. 124 1994 307 313
169. A. Sorkin C.M. Waters Endocytosis of growth factor receptors BioEssays 15 1993 375 381
170. M.B. Sporn A.B. Roberts Autocrine growth factors and cancer Nature 313 1985 745 747
171. M.J. Stone E.A. Sausville J.W. Fay D. Headlee R.H. Collins A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37dgA, in patients with B-cell lymphoma Blood 88 1996 1188 1197
172. E. Tagliabue F. Centis M. Campiglio A. Mastroianni S. Martignone Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/neu gene amplification Int. J. Cancer 47 1991 933 937
173. E. Tischer R. Mitchell T. Hartman M. Silva D. Gospodarowicz The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing J. Biol. Chem. 266 1991 11947 11954
174. G. Toffoli C. Cernigoi A. Russo A. Gallo M. Bagnoli M. Boiocchi Overexpression of folate binding protein in ovarian cancers Int. J. Cancer 74 1997 193 198
175. M. Toi A. Osaki H. Yamada T. Toge Epidermal growth factor receptor expression as a prognostic indicator in breast cancer Eur. J. Cancer 27 1991 977 980
176. A.W. Tolcher S. Sugarman K.A. Gelmon R. Cohen M. Saleh Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer J. Clin. Oncol. 17 1999 478 484
177. J.J. Turek C.P. Leamon P.S. Low Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells J. Cell Sci. 106 1993 423 430
178. F.M. Uckun R.K. Narla X. Jun T. Zeren T. Venkatachalam Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells Clin. Cancer Res 4 1998 901 912
179. S. Unezaki K. Mauryama O. Ishida A. Suginaka H. Jun-ichi M. Iwatsuru Enhanced tumor targeting and improved antitumor activity of doxorubicin by long-circulating liposomes containing amphipathic poly(ethylene glycol) Int. J. Pharmaceut. 126 1995 41 48
180. P.C. Uster T.M. Allen B.E. Daniels C.J. Mendez M.S. Newman G.Z. Zhu Inseretion of poly(ethylene glycol) derivatized phospholipid into preformed liposomes results in prolonged in vivo circulation time FEBS Lett. 386 1996 243 246
181. V. Valero A.U. Buzdar R.L. Theriault N. Azarnia G.A. Fonseca Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer J. Clin. Oncol. 17 1999 1425 1434
182. E.S. Vitetta M. Stone P. Amlot J. Fay R. May Phase I immunotoxin trial in patients with B-cell lymphoma Cancer Res. 51 1991 4052 4058
183. S. Wang P.S. Low Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells J. Controlled Release 53 1998 39 48
184. S. Wang R.J. Lee G. Cauchon D.G. Gorenstein P.S. Low Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol Proc. Natl. Acad. Sci. USA 92 1995 3318 3322
185. 67Ga-Deferoxamine-folate, a potential radiopharmaceutical for tumor imaging Bioconjugate Chem. 7 1996 56 62
186. M.C. Woodle D.D. Lasic Sterically stabilized liposomes Biochim. Biophys. Acta 1113 1992 171 199
187. S.D. Weitman R.H. Lark L.R. Coney D.W. Fort V. Frasca V.R. Zurawski Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues Cancer Res. 52 1992 3396 3401
188. D.S. Wilbur P.M. Pathare D.K. Hamlin S.P. Rothenberg E.V. Quadros Radioiodination of cyanocobalamin conjugates containing hydrophilic linkers: Preparation of a radioiodinated cyanocobalamin monomer and two dimers, and assesment of their binding with transcoblamin II Bioconj. Chem. 10 1999 912 920
189. M.C. Willis B. Collins T. Zhang L.S. Green D.P. Sebesta Liposomeanchored vascular endothelial growth factor aptamers Bioconj. Chem. 9 1998 573 582
190. J.Y. Wong T.L. Kuhl J.N. Israelachvili N. Mullah S. Zalipsky Direct measurement of a tethered ligand-receptor interaction potential Science 275 1997 820 822
191. D. Yu M.-C. Hung Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells Oncogene 6 1991 1991 1996
192. D. Yu A. Matin W. Xia F. Sorgi L. Huang M.C. Hung Liposome-mediated in vivo E 1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu Oncogene 11 1995 1383 1388
193. D. Yu S.-S. Wang K.M. Dulski C.-M. Tsai G.L. Nicolson M.-C. Hung C-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties Cancer Res. 54 1994 3260 3266
194. S. Zalipsky J. Gittelman N. Mullah M.M. Qazen J.A. Harding Biologically active ligand-bearing polymer-grafted liposomes G. Gregoriadis F. McCormack Targeting of Drugs: Strategies for Stealth Therapeutic Systems Vol. 6 1998 Plenum New York 131 138
195. S. Zalipsky C.B. Hansen D.E. Lopes de Menezes T.M. Allen Longcirculating, polyethylene glycol-grafted immunoliposomes J. Controlled Release 39 1996 153 161
196. J. Zimmerman Folic acid transport in organ-cultured mucosa of human intestine. Evidence for distinct carriers Gastroenterology 99 1990 964 972